Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juan Francisco Oteo has a total of 663 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement

    by Antonin Trimaille, Pedro Cepas-Guillén, Marina Urena, Alberto Alperi, Gabriela Veiga-Fernandez, Luis Nombela-Franco, Victoria Vilalta, Maria del Trigo, Antonio J. Muñoz-García, Giovanni Esposito, et al.

    BACKGROUND: Data on the long-term incidence and clinical impact of bioprosthetic valve failure (BVF) after transcatheter aortic valve replacement remain limited. This study aimed to assess the incidence, predictors, and clinical impact of BVF following transcatheter aortic valve replacement. METHODS: We analyzed data from an international, multicenter registry including consecutive patients undergoing transcatheter aortic valve replacement at 13 centers. The primary outcome was BVF according to Valve Academic Research Consortium-3 criteria. The cumulative incidence of BVF was estimated using a competing-risk approach. The association between BVF and clinical outcomes was assessed using competing-risk models with BVF as a time-dependent covariate. RESULTS: Among 7501 patients, BVF occurred in 380 (5.1%) patients over a median follow-up of 4 (interquartile range, 2–5) years. The cumulative incidence of BVF increased over time, reaching 1.4% at 1 year, 4.6% at 5 years, and 8.3% at 10 years. Independent predictors of BVF included younger age, smoking, balloon-expandable valve, prosthesis size P P P =0.043), and heart failure hospitalization (adjusted hazard ratio, 1.43 [95% CI, 1.03–1.98]; P =0.032). Consistent findings were observed in different sensitivity analyses. CONCLUSIONS: BVF is a clinically relevant event associated with adverse long-term outcomes. These findings support the implementation of tailored surveillance and preventive strategies to mitigate BVF-related risk.

  • Open Access

    Late Repair of Aortic Pseudoaneurysm After Trans-Femoral Aortic Valve Implantation

    by Juan Esteban de Villarreal-Soto, Juan Francisco Oteo-Domínguez, Alberto Forteza-Gil

    We present the case of a patient who underwent transcatheter aortic valve implantation and subsequently developed an aortic pseudoaneurysm. During follow-up, the patient appeared clinically and radiologically stable, although the imaging modalities employed were not adequate to fully assess the lesion. Ten months later, a thoracoabdominal computed tomography scan performed for an unrelated reason revealed significant pseudoaneurysm growth, and the patient subsequently underwent complex aortic root surgery. Central Message: Different degrees of iatrogenic aortic annulus rupture after TAVI lead to different therapeutic approaches; once the acute phase is over it requires close follow-up with appropriate imaging techniques.

  • Open Access

    Surgical Versus Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: 1‐Year Clinical Outcomes in Patients Aged 65 Years and Older

    by Kimberley Iris Hemelrijk, Matias R Mon Noboa, Gabriela Tirado‐Conte, Toon Winkelman, Lluis Asmarats, Elena Rosello‐Diez, Daniel Perez‐Camargo, Yusuke Kobari, Thibaut Guitteny, Angela McInerney, et al.

    Background: Transcatheter aortic valve replacement (TAVR) has shown noninferiority to surgical aortic valve replacement (SAVR). However, patients with bicuspid aortic stenosis are often excluded from these studies. More insights between these procedures in this population is crucial for treatment selection. Methods: In this multicenter observational study, patients with bicuspid aortic stenosis undergoing TAVR or SAVR were analyzed using propensity score matching. The primary outcome was a composite of all‐cause mortality, stroke, rehospitalization, or valve dysfunction at 1 year. Results: A total of 997 patients with bicuspid aortic stenosis underwent TAVR or SAVR. In the matched cohort of 256 pairs, the median age was 75.0 years (interquartile range, 71.0–78.0), 234 (44.9%) were women, and the median EuroScore II was 1.83% (interquartile range, 1.34–2.86). One‐year cumulative incidence of the primary outcome was 15.0% in TAVR compared with 12.0% in SAVR (hazard ratio [HR], 1.35 [95% CI, 0.83–2.19], P =0.23). Mortality (4.3% versus 5.0%, P =0.72) and rehospitalization (4.8% versus 6.4%, P =0.45) were similar between groups. Although rates of valve dysfunction (2.9% versus 0.5%, P =0.06) and stroke (5.3% versus 2.3%, P =0.10) were numerically lower in the surgical group at 1 year, both the risk of stroke (subdistribution HR, 3.01, P =0.02) and valve dysfunction (subdistribution HR, 4.16, P =0.03) were significantly higher in the TAVR group at 2 years. Conclusions: TAVR in patients with bicuspid aortic stenosis showed a similar 1‐year primary outcome rate compared with SAVR, though TAVR exhibited higher rates of valve dysfunction and stroke. These findings underscore the need for randomized trials to define the optimal treatment strategy for this population.


  • Open Access

    Patient-Specific Computational Hemodynamic Modeling of the Right Pulmonary Artery Using CardioMEMS Data: Validation, Simplification, and Sensitivity Analysis

    by Angélica Casero, Laura G. Sánchez, Felicia Alfano, Pedro Navas, Juan F. Oteo, Carlos Arellano-Serrano, Manuel Gómez-Bueno

    This study investigates the application of computational hemodynamic modeling, involving both FSI and CFD models, using SimVascular to simulate blood flow in the right pulmonary artery for patient-specific cardiovascular assessment. The artery’s three-dimensional geometry was reconstructed from a computed tomography (CT) image, and pressure measurements from a CardioMEMS™ device were used as clinical ground truth for validation. To represent the arterial hemodynamics, we initially formulated a fluid–structure interaction (FSI) approach to capture wall mechanics. However, given the high computational cost of fully patient-specific FSI simulations for routine clinical decision-making, we evaluated the validity of key simplifications by assuming rigid vessel walls coupled with a three-element Windkessel (3WK) model and applying a half-sine inflow waveform derived from the patient’s cardiac output. These simplifications yielded results with minimal error: the rigid-wall assumption introduced a 1.1% deviation, while the idealized waveform resulted in a 0.56 mmHg offset. Crucially, while wall rigidity was acceptable, we found that arterial compliance in the boundary conditions is non-negotiable; reducing the model to a pure resistance approach resulted in non-physiological pressures (130 mmHg). A subsequent parametric analysis examined how varying resistance (R) and compliance (C) distinctively alter the pressure waveform morphology. The results underscore the potential of combining remote monitoring data with validated computational simulations to deepen the understanding of cardiovascular dynamics and enhance diagnostic and therapeutic approaches for cardiovascular diseases.

  • Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR

    by Marisa Avvedimento, Pedro Cepas-Guillén, Julien Ternacle, Marina Urena, Alberto Alperi, Asim Cheema, Gabriela Veiga-Fernandez, Luis Nombela-Franco, Victoria Vilalta, Giovanni Esposito, et al.

    BACKGROUND: The Valve Academic Research Consortium for High Bleeding Risk (VARC-HBR) has recently introduced a consensus document that outlines risk factors to identify high bleeding risk in patients undergoing transcatheter aortic valve replacement. The objective of the present study was to evaluate the prevalence and predictive value of the VARC-HBR definition in a contemporary, large-scale transcatheter aortic valve replacement population. METHODS: Multicenter study including 10 449 patients undergoing transcatheter aortic valve replacement. Based on consensus, 21 clinical and laboratory criteria were identified and classified as major or minor. Patients were stratified as at low, moderate, high, and very high bleeding risk according to the VARC-HBR definition. The primary end point was the rate of Bleeding Academic Research Consortium type 3 or 5 bleeding at 1 year, defined as the composite of periprocedural (within 30 days) or late (after 30 days) bleeding. RESULTS: Patients with at least 1 VARC-HBR criterion (n=9267, 88.7%) had a higher risk of Bleeding Academic Research Consortium 3 or 5 bleeding, proportional to the severity of risk assessment (10.8%, 16.1%, and 24.6% for moderate, high, and very-high-risk groups, respectively). However, a comparable rate of bleeding events was observed in the low-risk and moderate-risk groups. The area under receiver operating characteristic curve was 0.58. Patients with VARC-HBR criteria also exhibited a gradual increase in 1-year all-cause mortality, with an up to 2-fold increased mortality risk for high and very-high-risk groups (hazard ratio, 1.33 [95% CI, 1.04–1.70] and 1.97 [95% CI, 1.53–2.53], respectively). CONCLUSIONS: The VARC-HBR consensus offered a pragmatic approach to guide bleeding risk stratification in transcatheter aortic valve replacement. The results of the present study would support the predictive validity of the new definition and promote its application in clinical practice to minimize bleeding risk and improve patient outcomes.


  • Open Access

    Ventricular Fibrillation during Optical Coherence Tomography

    by Paula Vela Martín, Carlos Arellano Serrano, Álvaro Lorente Ros, Juan Francisco Oteo, Arturo Garcia-Touchard

    Optical Coherence Tomography (OCT) imaging is a valuable tool for complex coronary interventions. While complications are rare, the occurrence of ventricular arrhythmias during its use is one of the most feared. Unfortunately, the mechanism by which these arrhythmias arise remains unclear. We describe the case of a patient under continuous electrocardiographic (ECG) monitoring who experienced ventricular fibrillation during an OCT procedure. A detailed analysis of the ECG event sequence was performed, from the administration of the contrast medium to the onset of ventricular fibrillation. Utilizing the collected data, we examined potential precipitating factors based on the observed alterations in the electrocardiogram. A comprehensive understanding of the mechanisms underlying these arrhythmias is crucial for the development of preventive measures that avoid such incidents in the future.

  • Open Access

    Valve Hemodynamics by Valve Size and 1-Year Survival Following Implantation of the Portico Valve in the Multicenter CONFIDENCE Registry

    by Helge Möllmann, Axel Linke, Luis Nombela-Franco, Martin Sluka, Juan Francisco Oteo Dominguez, Matteo Montorfano, Won-Keun Kim, Martin Arnold, Mariuca Vasa-Nicotera, Stephan Fichtlscherer, et al.


  • Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience

    by Vassili Panagides, Asim N. Cheema, Marina Urena, Luis Nombela-Franco, Gabriela Veiga-Fernandez, Victoria Vilalta, Ander Regueiro, David Del Val, Lluis Asmarats, Maria del Trigo, et al.

    Background: The potential benefit of using larger or smaller transcatheter heart valves (THV) in patients with borderline aortic annulus measurement (BAM) remains uncertain. The objective of this study was to evaluate the clinical outcomes associated with the selection of larger or smaller THV in the context of BAM. Methods: This was a multicenter observational study including patients who underwent transcatheter aortic valve replacement with the SAPIEN 3 or SAPIEN 3 Ultra-valve systems (Edwards Lifesciences, Irvine, CA) from April 2014 to June 2021. BAM was defined according to the manufacturer sizing chart and included the following annulus areas: 314 to 346, 400 to 430, 500 to 546 mm 2 . A 1:1 propensity score matching was used to compare outcomes of patients with larger or smaller THV. Results: From a total of 2467 patients, BAM was identified in 852 patients (34.5%). A larger and smaller THV was selected in 338 (39.7%) and 514 patients (60.3%) patients, respectively. The choice of a larger THV was associated (before and after propensity matching) with a higher risk of new-onset left bundle branch block (HR, 2.25 [95% CI, 1.39–3.65; P =0.001) and permanent pacemaker implantation (HR, 1.86 [95% CI, 1.11–3.09]; P =0.016) without any impact on gradients or the risk of moderate or severe paravalvular regurgitation at discharge (HR, 0.78 [95% CI, 0.41–1.45]; P =0.427). The risk of periprocedural complications such as aortic rupture and tamponade was low (<1%) and similar between groups. Conclusions: In patient with BAM, selecting a larger SAPIEN 3/Ultra THV increased the risk of conduction disturbances without any benefit on valve hemodynamics and clinical outcomes.


  • Open Access

    “Floating” Stent in a Coronary Aneurysm Presenting as ST-Elevation Myocardial Infarction

    by Daniel De Castro, Sergio García-Gómez, Fernando Domínguez, Carlos Arellano, Juan Francisco Oteo

    Coronary artery aneurysm (CAA) presenting as an ST-elevation myocardial infarction (STEMI) represents a clinical challenge due to the technical difficulties in the percutaneous management of this specific situation. Appropriate treatment for CAA depends on the precise clinical situation and consists of medical management, surgical resection, or/and stent placement. The high rate of complications during percutaneous intervention (distal thrombus embolization, no-reflow phenomenon, stent malposition, or dissection) makes emergent surgery a frequent situation in these cases. We present the case of a 50-year-old man with a STEMI due to thrombotic occlusion of CAA. Specific angiographic techniques and intracoronary imaging help with the percutaneous management of acute thrombotic occlusions in CAA, providing a less invasive approach than emergent surgery.


  • Open Access

    Risk of Infective Endocarditis Associated with Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: A Propensity Score-Based Analysis

    by Jorge Calderón-Parra, Juan E. de Villarreal-Soto, Juan Francisco Oteo-Domínguez, María Mateos-Seirul, Elsa Ríos-Rosado, Laura Dorado, Beatriz Vera-Puente, Carlos Arellano-Serrano, Antonio Ramos-Martínez, Alberto Forteza-Gil

    Background: Infective endocarditis (IE) is a feared complication after surgical aortic valve replacement (SAVR)/transcatheter aortic valve implantation (TAVI). It is not certain which procedure carries a higher risk. Our aim was to assess the risk of IE after SAVR/TAVI. Methods: We conducted an observational study of a prospective cohort, including patients with TAVI/SAVR, from March 2015 to December 2020. IE was defined according to the modified Duke’s criteria. IE occurring during the first 12 months of the procedure was considered early IE, and an episode occurring after 12 months was considered late IE. The propensity score was designed to include variables previously associated with TAVI/SAVR and IE. An inverse probability of treatment weight was generated. Results: In total, 355 SAVR and 278 TAVI were included. Median follow-up, 38 vs. 41 months, p = 0.550. IE occurred in 5 SAVR (1.41%, 95% CI 0.2–2.6) vs. 13 TAVI (4.65%, 95% CI 2.2–7.2), p = 0.016. TAVI patients had more frequent early IE (3.2% vs. 0.3%, p = 0.006). In the PS analyses, IE risk did not differ: OR 0.65, 95% CI 0.32–1.32. Factors associated with TAVI IE included younger age (74y vs. 83y, p = 0.030), complicated diabetes mellitus (38.5% vs. 6.8%, p = 0.002), COPD (46.2% vs. 16.3%, p = 0.015), advanced heart failure (100% vs. 52.9%, p < 0.001), and peripheral arteriopathy (61.5% vs. 26.7%, p = 0.011). Conclusions: Early IE was higher with TAVI, but in the PS analyses, the risk attributable to each procedure was similar. Studies are needed to identify and optimize the risk factors of IE prior to TAVI.